Abstract
Background
The potentially inappropriate use of the proton pump inhibitors is prevalent in older adults.
Aim
To evaluate the impact of a clinical pharmacist-led stewardship program for the appropriate use of acid suppression therapy in older hospitalized patients.
Method
This parallel nonrandomized controlled study was conducted at an internal medicine service of a tertiary training and research hospital between September 2019 and August 2021. Older patients (≥ 65 years old and received proton pump inhibitors within 48 h of admission) were allocated to two groups according to their number of medical file records, whether odd or even, two groups: control and clinical pharmacist-led stewardship program for the appropriate use of acid suppression therapy (including medication reconciliation and medication review) during the hospital stay. Primary outcome measures were the rate of appropriate use of proton pump inhibitors during hospitalization and potentially inappropriate proton pump inhibitor use at discharge.
Results
The rate of appropriate proton pump inhibitor use during hospitalization was significantly higher in the clinical pharmacist-led program (n = 100) than in the control group (n = 97) (46.4% vs. 79.0%; P < 0.001). The rate of potentially inappropriate proton pump inhibitor use at discharge was significantly lower (61.7% vs. 35.1%; P < 0.05) in the clinical pharmacist-led program among the older patients discharged with a proton pump inhibitor prescription.
Conclusion
A clinical pharmacist-led stewardship program for the appropriate use of acid suppression therapy improved the rate of appropriate proton pump inhibitor use and reduced the potentially inappropriate proton pump inhibitor use during the hospital stay.
Trial Registration
NCT05113667 (17 October 2021-registered retrospectively).
Similar content being viewed by others
References
Fagiano R, Falcone Y, Fonte G, et al. Indications, appropriateness and drug interactions of proton pump inhibitors prescribed at hospital discharge in older medical patients. Geriatr Gerontol Int. 2017;17(8):1238–40. doi:https://doi.org/10.1111/ggi.13043.
Fralick M, Bartsch E, Ritchie CS, et al. Estimating the Use of Potentially Inappropriate Medications Among Older Adults in the United States. J Am Geriatr Soc. 2020;68(12):2927–30. doi:https://doi.org/10.1111/jgs.16779.
Urzal J, Pedro AB, Oliveira IF. et. al. Inappropriate Prescribing to Elderly Patients in an Internal Medicine Ward. Acta Med Port. 2019;32(2):141–8. doi:https://doi.org/10.20344/amp.10683.
Franchi C, Mannucci PM, Nobili A, et al. Use and prescription appropriateness of drugs for peptic ulcer and gastrooesophageal reflux disease in hospitalized older people. Eur J Clin Pharmacol. 2020;76(3):459–65. doi:https://doi.org/10.1007/s00228-019-02815-w.
Alshehri S, Alshibani M, Magboul G. et. al. Adherence to Beers Criteria in Geriatrics: A Retrospective Study in a Saudi Teaching Hospital. Geriatr (Basel). 2020;5(4):97. doi:https://doi.org/10.3390/geriatrics5040097.
Di Martino E, Provenzani A, Polidori P. Evidence-based application of explicit criteria to assess the appropriateness of geriatric prescriptions at admission and hospital stay. PLoS One. 2020;15(8):e0238064. doi:https://doi.org/10.1371/journal.pone.0238064.
Mekonnen AB, Redley B, de Courten B, et al. Potentially inappropriate prescribing and its associations with health-related and system-related outcomes in hospitalised older adults: A systematic review and meta-analysis. Br J Clin Pharmacol. 2021;87(11):4150-4172. doi:https://doi.org/10.1111/bcp.14870. Epub ahead of print.
Yadesa TM, Kitutu FE, Deyno S, et al. Prevalence, characteristics and predicting risk factors of adverse drug reactions among hospitalized older adults: A systematic review and meta-analysis. SAGE Open Med. 2021;9:20503121211039099. doi:https://doi.org/10.1177/20503121211039099.
Wolfe MM. Proton pump inhibitors: Overview of use and adverse effects in the treatment of acid related disorders. https://www.uptodate.com/contents/proton-pump-inhibitors-overview-of-use-and-adverse-effects-in-the-treatment-of-acid-relateddisorders. Accessed 01.05.2021.
Wilsdon TD, Hendrix I, Thynne TR, et al. Effectiveness of Interventions to Deprescribe Inappropriate Proton Pump Inhibitors in Older Adults. Drugs Aging. 2017;34(4):265–87. doi:https://doi.org/10.1007/s40266-017-0442-1.
Orelio CC, Heus P, Kroese-van Dieren JJ, et al. Reducing Inappropriate Proton Pump Inhibitors Use for Stress Ulcer Prophylaxis in Hospitalized Patients: Systematic Review of De-Implementation Studies. J Gen Intern Med. 2021;36(7):2065–73. doi:https://doi.org/10.1007/s11606-020-06425-6.
Thillainadesan J, Gnjidic D, Green S, et al. Impact of Deprescribing Interventions in Older Hospitalised Patients on Prescribing and Clinical Outcomes: A Systematic Review of Randomised Trials. Drugs Aging. 2018;35(4):303–19. doi:https://doi.org/10.1007/s40266-018-0536-4.
Singh-Franco D, Mastropietro DR, Metzner M, et al. Impact of pharmacy-supported interventions on proportion of patients receiving non-indicated acid suppressive therapy upon discharge: A systematic review and meta-analysis. PLoS One. 2020;15(12):e0243134. doi:https://doi.org/10.1371/journal.pone.0243134.
Mansur JM. Medication Safety Systems and the Important Role of Pharmacists. Drugs Aging. 2016;33(3):213–21. doi:https://doi.org/10.1007/s40266-016-0358-1.
Des Jarlais DC, Lyles C, Crepaz N, et al. Improving the reporting quality of nonrandomized evaluations of behavioral and public health interventions: the TREND statement. Am J Public Health. 2004;94(3):361–6. doi:https://doi.org/10.2105/ajph.94.3.361.
Hoffmann TC, Glasziou PP, Boutron I, et al. Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide. BMJ. 2014;348:g1687. doi:https://doi.org/10.1136/bmj.g1687.
De Rijdt T, Spriet I, Willems L, et al. Appropriateness of Acid Suppression Therapy. Ann Pharmacother. 2017;51(2):125–34. doi:https://doi.org/10.1177/1060028016670414.
Wan A, Halpape K, Talkhi SC, et al. Evaluation of prescribing appropriateness and initiatives to improve prescribing of proton pump inhibitors at Vancouver General Hospital. Can J Hosp Pharm. 2018;71(5):308–15.
Farrell B, Pottie K, Thompson W, et al. Deprescribing proton pump inhibitors. Can Fam Physician. 2017;63:354–64.
American Society of Health-System Pharmacists. ASHP therapeutic guidelines on stress ulcer prophylaxis. ASHP commission on therapeutics and approved by the ASHP Board of Directors on November 14, 1998. Am J Health Syst Pharm. 1999;56(4):347–79.20. doi:https://doi.org/10.1093/ajhp/56.4.347.
Hanlon JT, Schmader KE. The medication appropriateness index at 20: where it started, where it has been, and where it may be going. Drugs Aging. 2013;30(11):893–900. doi:https://doi.org/10.1007/s40266-013-0118-4.
Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–83. doi:https://doi.org/10.1016/0021-9681(87)90171-8.
American Geriatrics Society. 2019 Updated AGS Beers Criteria® for Potentially Inappropriate Medication Use in Older Adults. By the 2019 American Geriatrics Society Beers Criteria® Update Expert Panel. J Am Geriatr Soc. 2019;67(4):674–94. doi:https://doi.org/10.1111/jgs.15767.
Pasina L, Nobili A, Tettamanti M, et al. Prevalence and appropriateness of drug prescriptions for peptic ulcer and gastro-esophageal reflux disease in a cohort of hospitalized elderly. Eur J Intern Med. 2011;22(2):205–10. doi:https://doi.org/10.1016/j.ejim.2010.11.009.
Michal J, Henry T, Street C. Impact of a pharmacist-driven protocol to decrease proton pump inhibitor use in non-intensive care hospitalized adults. Am J Health Syst Pharm. 2016;73(17 Suppl 4):126-32. doi:https://doi.org/10.2146/ajhp150519.
Khalili H, Dashti-Khavidaki S, Hossein Talasaz AH, et al. Descriptive analysis of a clinical pharmacy intervention to improve the appropriate use of stress ulcer prophylaxis in a hospital infectious disease ward. J Manag Care Pharm. 2010;16(2):114–21. doi:https://doi.org/10.18553/jmcp.2010.16.2.114.
Khudair IF, Sadik ND, Hanssens Y, et al. Impact of multi-approach strategy on acid suppressive medication use in a teaching hospital in Qatar. Int J Clin Pharm. 2011;33(5):763–71. doi:https://doi.org/10.1007/s11096-011-9531-0.
Hamzat H, Sun H, Ford JC, et al. Inappropriate prescribing of proton pump inhibitors in older patients: effects of an educational strategy. Drugs Aging. 2012;29(8):681–90. doi:https://doi.org/10.1007/BF03262283.
Atkins R, Smith L. Impact of pharmacy intervention on the use of proton-pump inhibitors in the hospital setting. Consult Pharm. 2013;28(12):786–92. doi:https://doi.org/10.4140/TCP.n.2013.786.
Buckley MS, Park AS, Anderson CS, et al. Impact of a clinical pharmacist stress ulcer prophylaxis management program on inappropriate use in hospitalized patients. Am J Med. 2015;128(8):905–13. doi:https://doi.org/10.1016/j.amjmed.2015.02.014.
Xin C, Dong Z, Lin M, et al. The impact of pharmaceutical interventions on the rational use of proton pump inhibitors in a Chinese hospital. Patient Prefer Adherence. 2017;12:21–6. doi:https://doi.org/10.2147/PPA.S150388.
Luo H, Fan Q, Xiao S, et al. Impact of clinical pharmacist interventions on inappropriate prophylactic acid suppressant use in hepatobiliary surgical patients undergoing elective operations. PLoS One. 2017;12(10):e0186302. doi:https://doi.org/10.1371/journal.pone.0186302.
Pestka DL, Sorge LA, McClurg MR, et al. The Philosophy of Practice for Comprehensive Medication Management: Evaluating Its Meaning and Application by Practitioners. Pharmacotherapy. 2018;38(1):69–79. doi:https://doi.org/10.1002/phar.2062.
Acknowledgements
None.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Funding
None.
Conflicts of interest
The authors declare no conflict of interest.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Dumlu, H.I., Sancar, M., Ozdemir, A. et al. Impact of a clinical pharmacist-led stewardship program for the appropriate use of acid suppression therapy in older hospitalized patients: a non-randomized controlled study. Int J Clin Pharm 44, 914–921 (2022). https://doi.org/10.1007/s11096-022-01394-8
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11096-022-01394-8